Life360 (LIF) director reports option exercise and share sale

Q: What insider transaction did Life360 (LIF) report in this Form 4?

A director exercised a stock option to acquire 7,930 shares of Life360 common stock at $11.18 per share and sold 7,930 shares at $68.3 per share on 12/15/2025 .

Q: What stock options does the Life360 (LIF) director still hold?

The director holds 87,230 stock options with an exercise price of $11.18 per share, each option relating to Life360 common stock.

Q: What does the filing say about the vesting of the Life360 (LIF) stock option?

The option vests as to 1/2 of the shares on April 1, 2024 , then as to 1/24th of the total shares in equal monthly installments until fully vested, subject to continued service.

Filing Impact

(High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Life360, Inc. director reported an insider transaction involving stock options and common shares. On 12/15/2025, the director exercised a stock option to acquire 7,930 shares of common stock at $11.18 per share, then sold 7,930 shares of common stock at $68.3 per share under transaction codes M and S.

After these transactions, the director beneficially owned 105,456 shares of common stock, including 1,357 restricted stock units that each convert into one share upon vesting, and held 87,230 stock options at an exercise price of $11.18 per share. The filing states the trades were made under a pre-established Rule 10b5-1 trading plan adopted on March 14, 2025, and also corrects previously misreported vesting terms for the stock option.

Insider Trade Summary

Net Seller: 7,930 shares ($541,619)

Net Sell 3 txns

Insider Prober Charles J.

Role Director

Sold 7,930 shs ($542K)

Type	Security	Shares	Price	Value
Exercise	Stock Option (right to buy)	7,930	$0.00	--
Exercise	Common stock	7,930	$11.18	$89K
Sale	Common stock	7,930	$68.30	$542K

Holdings After Transaction: Stock Option (right to buy) — 87,230 shares (Direct); Common stock — 113,386 shares (Direct)

Footnotes (1)

The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. Includes 1,357 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. The stock option vests and becomes exercisable as to 1/2 of the total number of shares on April 1, 2024 and thereafter vests and becomes exercisable as to 1/24th of the total number of shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.

Form 4 Insider Transactions: What Each Field Means →

12/17/2025 - 06:11 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Prober Charles J.

(Last)

(First)

(Middle)

C/O LIFE360, INC.

1900 SOUTH NORFOLK STREET, SUITE 310

(Street)

SAN MATEO

94403

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Life360, Inc. [ LIF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common stock	12/15/2025		M⁽¹⁾		7,930	A	$11.18	113,386⁽²⁾	D
Common stock	12/15/2025		S⁽¹⁾		7,930	D	$68.3	105,456⁽²⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (right to buy)	$11.18	12/15/2025		M⁽¹⁾			7,930	⁽³⁾	04/12/2028	Common stock	7,930	$0	87,230	D

Explanation of Responses:

1. The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.

2. Includes 1,357 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

3. The stock option vests and becomes exercisable as to 1/2 of the total number of shares on April 1, 2024 and thereafter vests and becomes exercisable as to 1/24th of the total number of shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.

Remarks:

The vesting terms for the stock option reported herein were inadvertently misreported on the Reporting Person's initial Form 3 filed on June 27, 2022, Form 3/A filed on June 29, 2022, and subsequent Forms 4 reporting transactions in the stock option, and have been corrected as of this Form 4.

	/s/ Jay Sood, Attorney-in-Fact	12/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Life360 (LIF) report in this Form 4?

A director exercised a stock option to acquire 7,930 shares of Life360 common stock at $11.18 per share and sold 7,930 shares at $68.3 per share on 12/15/2025.

How many Life360 (LIF) shares does the director own after this transaction?

Following the reported trades, the director beneficially owned 105,456 shares of Life360 common stock, including 1,357 restricted stock units.

What stock options does the Life360 (LIF) director still hold?

The director holds 87,230 stock options with an exercise price of $11.18 per share, each option relating to Life360 common stock.

Was the Life360 (LIF) insider trade made under a Rule 10b5-1 plan?

Yes. The filing states the transaction was effected under a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2025.

What does the filing say about the vesting of the Life360 (LIF) stock option?

The option vests as to 1/2 of the shares on April 1, 2024, then as to 1/24th of the total shares in equal monthly installments until fully vested, subject to continued service.

Did Life360 (LIF) correct any prior reporting errors in this insider filing?

Yes. The filing notes that vesting terms for the stock option were previously misreported on earlier forms and have been corrected in this report.